相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Naomi Winick et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
Audrey Bonaventure et al.
LANCET HAEMATOLOGY (2017)
Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group
Uma H. Athale et al.
PEDIATRIC BLOOD & CANCER (2016)
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genomics in acute lymphoblastic leukaemia: insights and treatment implications
Kathryn G. Roberts et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays
Amaranto Suarez et al.
PEDIATRIC BLOOD & CANCER (2015)
Biology of Childhood Acute Lymphoblastic Leukernia
Deepa Bhojwani et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Pediatric Medical Care System in China Has Significantly Reduced Abandonment of Acute Lymphoblastic Leukemia Treatment
Qi Zhou et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Jan Stary et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Treatment of Childhood Acute Lymphoblastic Leukemia in Central America: A Lower-Middle Income Countries Experience
M. Navarrete et al.
PEDIATRIC BLOOD & CANCER (2014)
Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing, collaboration and partnerships
Gaston K. Rivera et al.
EXPERT REVIEW OF HEMATOLOGY (2014)
Improved outcome for children with non-high risk acute lymphoblastic leukaemia after using an ALL IC-BFM 2002-based protocol in Shanghai, China
Yi-Jin Gao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia
Stephen P. Hunger et al.
PEDIATRIC BLOOD & CANCER (2013)
Minimal Residual Disease-Based Risk Stratification in Chinese Childhood Acute Lymphoblastic Leukemia by Flow Cytometry and Plasma DNA Quantitative Polymerase Chain Reaction
Suk Hang Cheng et al.
PLOS ONE (2013)
Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in china with or without specific fusion transcripts: A single institutional study of 1,004 patients
Chao Gao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
Martin Schrappe et al.
BLOOD (2011)
A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007
Yan-rong Wang et al.
LEUKEMIA RESEARCH (2011)
Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia
D-C Liang et al.
LEUKEMIA (2010)
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report
P. S. Gaynon et al.
LEUKEMIA (2010)
Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia
Lei Cui et al.
LEUKEMIA RESEARCH (2010)
Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia
Zhigang Li et al.
BLOOD (2009)
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Ching-Hon Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
Anja Moericke et al.
BLOOD (2008)
Use of the International System for Human Cytogenetic Nomenclature (ISCN)
Juan Ramon Gonzalez Garcia et al.
BLOOD (2006)
分享论文
